Glatiramer acetate (Copaxone®) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis
Open Access
- 1 April 2000
- journal article
- clinical trial
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 105 (7), 967-976
- https://doi.org/10.1172/jci8970
Abstract
We examined the effect of glatiramer acetate, a random copolymer of alanine, lysine, glutamic acid, and tyrosine, on antigen-specific T-cell responses in patients with multiple sclerosis (MS). Glatiramer acetate (Copaxone) functioned as a universal antigen, inducing proliferation, independent of any prior exposure to the polymer, in T-cell lines prepared from MS or healthy subjects. However, for most patients, daily injections of glatiramer acetate abolished this T-cell response and promoted the secretion of IL-5 and IL-13, which are characteristic of Th2 cells. The surviving glatiramer acetate-reactive T cells exhibited a greater degree of degeneracy as measured by cross-reactive responses to combinatorial peptide libraries. Thus, it appears that, in some individuals, in vivo administration of glatiramer acetate induces highly cross-reactive T cells that secrete Th2 cytokines. To our knowledge, glatiramer acetate is the first agent that suppresses human autoimmune disease and alters immune function by engaging the T-cell receptor. This compound may be useful in a variety of autoimmune disorders in which immune deviation to a Th2 type of response is desirable.Keywords
This publication has 39 references indexed in Scilit:
- Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosisNeurology, 1995
- Specific T cell recognition of minimally homologous peptides: Evidence for multiple endogenous LigandsImmunity, 1995
- Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligandImmunity, 1995
- Reversal of experimental autoimmune encephalomyelitis by a soluble peptide variant of a myelin basic protein epitope: T cell receptor antagonism and reduction of interferon gamma and tumor necrosis factor alpha production.The Journal of Experimental Medicine, 1994
- Regulatory T Cell Clones Induced by Oral Tolerance: Suppression of Autoimmune EncephalomyelitisScience, 1994
- T Cell Deletion in High Antigen Dose Therapy of Autoimmune EncephalomyelitisScience, 1994
- Mapping T-cell receptor–peptide contacts by variant peptide immunization of single-chain transgenicsNature, 1992
- Separation of IL-4 Production from Th Cell Proliferation by an Altered T Cell Receptor LigandScience, 1991
- T Cells Responsive to Myelin Basic Protein in Patients with Multiple SclerosisScience, 1990
- Suppression of experimental allergic encephalomyelitis by a synthetic polypeptideEuropean Journal of Immunology, 1971